MNKD

MannKind
MNKD

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.13B
EV
$1.09B
Shares Outstanding
307.05M
Beta
1.01

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$9.71
P/E 2025E
19.10x
P/Revenue 2025E
3.54x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MannKind Corporation

gainify
MNKD

MannKind Corporation

MNKD

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in a...

Sector

Healthcare

Industry

Biotechnology

CEO

Castagna, Michael

Employees

405

IPO Date

2004-07-28

Headquarters

1 Casper Street, Danbury, Connecticut, 06810, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.